In melanoma, p53 mutations are significantly less common compared with the frequency observed in most other cancers so, in either case, the abnormal numbers of centrosomes in melanoma cannot be attributed to p53 loss (Fecher et al., 2007). This evidence concerns the gene TP53 and cancer.